| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.2 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.28 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.057 | 0.2 |